Cargando…
Functional single nucleotide polymorphisms in dopaminergic receptors D2 predict clinical response to Cariprazine
Cariprazine (CAR) is an antipsychotic drug for the treatment of schizophrenia (SCZ) and bipolar disorder (BD), and it acts as a partial agonist on the dopamine receptors (DR), D2, and D3. Although many single nucleotide polymorphisms (SNPs) in genes coding for these receptors are known to influence...
Autores principales: | De Pieri, Marco, Ferrari, Marco, Marino, Franca, Traber, Rafael, Bolla, Emilio, Cosentino, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203397/ https://www.ncbi.nlm.nih.gov/pubmed/37229261 http://dx.doi.org/10.3389/fphar.2023.1182393 |
Ejemplares similares
-
Case Report: Long-Acting Oral Cariprazine
por: Dyrmishi, Emanuela, et al.
Publicado: (2022) -
Clinical effects of Cariprazine and their relationship with polymorphisms of dopamine and serotonin receptors: preliminary results from a prospective study on schizophrenia and bipolar disorder
por: De Pieri, M., et al.
Publicado: (2022) -
Dopaminergic Receptors and Tyrosine Hydroxylase Expression in Peripheral Blood Mononuclear Cells: A Distinct Pattern in Central Obesity
por: Leite, Fernanda, et al.
Publicado: (2016) -
Dopaminergic regulation of inflammation and immunity in Parkinson's disease: friend or foe?
por: Furgiuele, Alessia, et al.
Publicado: (2023) -
Polymorphisms of Dopamine Receptor Genes and Parkinson’s Disease: Clinical Relevance and Future Perspectives
por: Magistrelli, Luca, et al.
Publicado: (2021)